These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14344130)

  • 1. [STUDIES ON THE CLEARANCE INDUCING EFFECTS OF A NATURAL HEPARINOID].
    WAGENER H; KRUSZEWSKA B; SCHULZ U
    Arzneimittelforschung; 1964 Aug; 14():879-83. PubMed ID: 14344130
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTION OF THE HEPARINOID, CB-8061, IN MAN. I. APPEARANCE OF PLASMA CLEARING CAPACITY AFTER INJECTION OF A SINGLE DOSE OF THE PRODUCT].
    DUREUX JB; BRIGNON JJ; MARCHAL C
    Therapie; 1964; 19():879-89. PubMed ID: 14190943
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPARISON OF SOME EFFECTS OF HEPARIN AND THE PERORAL HEPARINOID "ATEROID" IN RATS].
    CEPELIK J; CERNOHORSKY M
    Cas Lek Cesk; 1963 Nov; 102():1291-4. PubMed ID: 14111755
    [No Abstract]   [Full Text] [Related]  

  • 4. [HEPARINOIDS--PHYSIOLOGICAL PROPERTIES AND THERAPEUTIC INDICATIONS].
    GUILLEMAN P; HARDY N
    Rev Prat; 1964 Oct; 14():3391-405. PubMed ID: 14205831
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the behavior of the plasma "clearing factor" after the administration of a synthetic heparinoid].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1498-9. PubMed ID: 13807122
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect exercised by a heparinoid on hyperlipemia induced in the rabbit by a surface-active agent].
    BINET L; MARQUIS M; QUIVY D
    C R Hebd Seances Acad Sci; 1959 Dec; 249():2693-7. PubMed ID: 13800760
    [No Abstract]   [Full Text] [Related]  

  • 7. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 8. THE EFFECT OF TRIPARANOL AND OF HEPARINOID ON SPONTANEOUS ATHEROSCLEROSIS OF HENS.
    MALINOW MR; MARINI MA; LEMA B; NEBBIA M; BERARDI JA
    Acta Physiol Lat Am; 1964; 14():71-6. PubMed ID: 14175168
    [No Abstract]   [Full Text] [Related]  

  • 9. On the effect of alimentary lipemia and a natural heparinoid on the fibrinolytic system of man.
    KONTTINEN Y
    Scand J Clin Lab Invest; 1962; 14():87-99. PubMed ID: 14458289
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological studies on heparinoid SP 54].
    ODA T; YOSHIMOTO S
    Osaka City Med J; 1962 Dec; 11():319-25. PubMed ID: 13939447
    [No Abstract]   [Full Text] [Related]  

  • 11. [USE OF A SYNTHETIC HEPARINOID IN LIPID METABOLISM DISORDERS. PRELIMINARY STUDY].
    RABY C; SAINT-BLANCARD J; PAGE G; BIED B; VIGNE J; OUGIER J
    Sem Ther; 1963 Dec; 39():658-64. PubMed ID: 14116089
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE ANTITHROMBIN EFFECT OF HEPARINOIDS IN VIVO. 3. ON THE MECHANISM OF ACTION OF HEPARINOIDS].
    PULVER R
    Arzneimittelforschung; 1963 Nov; 13():1010-1. PubMed ID: 14210418
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the clarifying activity in vitro of serum after the addition of various heparinoid substances].
    WOLFF R; BRIGNON JJ
    Arch Int Pharmacodyn Ther; 1959 Sep; 121():255-67. PubMed ID: 13845713
    [No Abstract]   [Full Text] [Related]  

  • 14. [DISPERSIVE EFFECT OF A SYNTHETIC HEPARINOID. EXPERIMENTAL STUDY].
    THIEBLOT L; BLAISE S; BIDET JM
    C R Seances Soc Biol Fil; 1964; 158():2351-3. PubMed ID: 14289097
    [No Abstract]   [Full Text] [Related]  

  • 15. [INFLUENCE OF A SYNTHETIC HEPARINOID (SP-54) ON THE TIME OF REABSORPTION OF EXPERIMENTAL HYPHEMIA IN RABBITS].
    BROGI M; LAMPIS R; PANDOLFI M
    Ann Ottalmol Clin Ocul; 1963 Dec; 89():SUPPL:1147-50. PubMed ID: 14174445
    [No Abstract]   [Full Text] [Related]  

  • 16. [LIPOLYTIC ACTIVITY OF SOME ANTI-ATHEROSCLEROTIC DRUGS].
    SCHOEN H; SAUER M
    Arzneimittelforschung; 1963 Aug; 13():718-22. PubMed ID: 14085927
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 18. [The blood, hepatic and aortic lipids in chronic experimental carbon disulfide poisoning in rabbits. Action of duodenal heparinoid extract].
    NICROSINI F; PASOTTI C; DEL FAVERO A; RICOTTI V; MARCHESI E
    Arch Sci Med (Torino); 1963 Feb; 115():109-28. PubMed ID: 13938462
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the clearing action of a heparinoid obtained from duodenal mucosa].
    HAMMERL H; PICHLER O
    Clin Ter; 1963 May; 25():250-7. PubMed ID: 13952389
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of a new p-tert-octylphenol derivative on the clearing factor and on the plasma lipids of rabbits.
    VAN DEN BOSCH J; EVRARD E; BILLIAU A; DE SOMER P; JOOSSENS JV
    J Atheroscler Res; 1961; 1():148-62. PubMed ID: 13779921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.